OKYO Pharma Limited (OKYO) concluded trading on Wednesday at a closing price of $1.07, with 4.0 million shares of worth about $4.28 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -14.40% during that period and on January 29, 2025 the price saw a gain of about 3.28%. Currently the company’s common shares owned by public are about 1.42B shares, out of which, 24.54M shares are available for trading.
Stock saw a price change of 3.25% in past 5 days and over the past one month there was a price change of 0.00%. Year-to-date (YTD), OKYO shares are showing a performance of -6.95% which decreased to -32.49% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.81 but also hit the highest price of $1.90 during that period. The average intraday trading volume for OKYO Pharma Limited shares is 58.80K. The stock is currently trading -1.54% below its 20-day simple moving average (SMA20), while that difference is up 0.17% for SMA50 and it goes to -9.86% lower than SMA200.
OKYO Pharma Limited (NASDAQ: OKYO) currently have 1.42B outstanding shares and institutions hold larger chunk of about 2.96% of that.
The stock has a current market capitalization of $36.26M and its 3Y-monthly beta is at -0.28. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OKYO, volatility over the week remained 11.37% while standing at 9.68% over the month.
Stock’s fiscal year EPS is expected to rise by 5.00%.
